Aclaris Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference

MALVERN, Pa., July 05, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that Dr. Neal Walker, President & Chief Executive Officer, will present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on Tuesday, July 12, 2016 at 2:30 p.m. Eastern Time. The conference will be held at the Le Parker Meridien Hotel in New York, NY.

A live audio webcast of the Aclaris presentation may be accessed by visiting the “Investors” section of the Company’s website at www.aclaristx.com. A replay of the webcast will be archived on the Aclaris website for 14 days following the presentation date.

About Aclaris
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology. Aclaris Therapeutics, Inc. is based in Malvern, Pennsylvania and more information can be found by visiting the company’s website at www.aclaristx.com.

Contact: Aclaris Contact Frank Ruffo Chief Financial Officer 484-324-7933 investors@aclaristx.com Investor Contact Patricia L. Bank Westwicke Partners Managing Director 415-513-1284 patti.bank@westwicke.com Media Contact Mariann Caprino TogoRun 917-242-1087 M.Caprino@togorun.com

Source:Aclaris Therapeutics, Inc.